FDA 483 - Plastiape Spa - July 30, 2015

An FDA inspection of Plastiape Spa, a medical device manufacturer in Osnago, Italy, revealed significant deficiencies in its quality system. Observations included inadequate procedures for supplier corrective actions, management review, and internal quality audits. These issues indicate a lack of robust oversight and control over critical quality processes.